Senior insider sale
Chief Financial Officer at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$4.79M
60K shares
What this filing means
GORDON STEPHEN plans to sell 60K shares of TRANSMEDICS GROUP, INC. valued at approximately $4.79M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/1/2024ACC: 0001959173-24-002684
Officer· Chief Financial Officer
Since May 2019
60K
Shares to sell
$4.79M
Approx. market value
15K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise Grant Date 2/24/2021
Wire
4/1/2024
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2024 | Stock Option Exercise Grant Date 2/24/2021 Wire | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
15K
Market value
$1.24M
3/4/2024
—Completed
Units to sell
15K
Market value
$1.28M
2/1/2024
—Completed
Units to sell
15K
Market value
$1.16M
1/2/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
15K
Market value
$1.11M
4/1/2024
Total
Units
60K
Value
$4.79M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2024 | 15K | $1.24M | — | Completed |
2/1/2024 | 15K | $1.28M | — | Completed |
1/2/2024 | 15K | $1.16M | — | Completed |
| Planned — Approximate Date | ||||
4/1/2024 | 15K | $1.11M | NASDAQ | Planned |
| Total | 60K | $4.79M | ||